Overall verdict
Neutral
5.2/10
1-year performance
+7.34%
Score breakdown
Up 7.3% over 1 year, 33% of the 52-week range.
Strongest: Profitability 7.9/10. Weakest: Valuation 2.1/10.
15 analysts, target +0.0% vs the price.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States.
The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Sector
Financials
Industry
Insurance
Primary listing
Nyse
United States
CEO
Daniel Amos
Founded
1955
Employees
12 716
Revenue / employee
1.3M USD
Next earnings
November 4, 2026
Institutional holders
- Japan Post Holdings Co., Ltd.10.00%
- BlackRock, Inc.6.86%
- VANGUARD CAPITAL MANAGEMENT LLC5.88%
- VANGUARD PORTFOLIO MANAGEMENT LLC4.79%
- STATE STREET CORP4.62%
- GEODE CAPITAL MANAGEMENT, LLC2.08%
- WELLS FARGO & COMPANY/MN1.70%
- MORGAN STANLEY1.58%
- NORTHERN TRUST CORP1.23%
- Other institutions28.69%
- Rest of the register32.57%
1691 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
130.22 USD
52-week low
105.43 USD
1-year performance
7.34%
Rising
Year-to-date performance
4.62%
Rising
Drawdown
-12.84%
Mild pullback
Position in the 52-week range
33% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned more, but shaking 1.8 times harder: for the risk taken, the ETF paid better.
10,000 € placed at the end of September 2009 are worth today
| Aflac | 102 656 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 1.8 times as much as the world ETF.
- Worst fall:-53 % between July 2019 and March 2020. 10,000 € placed at the top fell to 4 677 €. The world ETF, at worst: -34 %. Back to its high in 17 months.
Aflac earned more than the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- Aflac: 102 656 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Based on past performance. This is not a recommendation.
Range: 99.56 USD - 138.00 USD (2 methods agree)
The price implies growth of 6.14% per year; the company grows at 0.43%.
Net margin 26.9%, ROIC 13.1%, ROE 16.9%.
Net margin
26.91%
Exceptional
Sector 5.97%|S&P 12.97%
Gross margin
—
Return on equity (ROE)
16.91%
High
Sector 12.93%|S&P 16.52%
Return on invested capital (ROIC)
13.15%
Exceptional
Free cash flow margin (FCF)
14.65%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.54x
Fair
Margin stability
5.0 pts
Uneven
Revenue to net income
Growth
5.1/10Revenue down 1.0% over 1 year, -5.0% a year over 5, EPS 0.4% a year over 5.
Revenue (trailing 12 months)
18.1Md USD
Revenue growth (1y)
-1.03%
Declining
Revenue growth (3y)
-10.32%
Declining
EPS growth (1y)
46.68%
Hyper-growth
EPS CAGR (5y)
0.43%
Low
EPS revisions (3 months)
-0.38%
Revised down
Valuation
2.1/10P/E 12.2x, forward P/E 16.0x, PEG 28.21. The multiple sits in the 95th percentile of its own 5-year history.
P/E (TTM)
12.2x
Fair
Sector 16.5x|S&P 23.0x
Forward P/E
16.0x
Expensive
EV / EBITDA
—
Sector 56.8x|S&P 14.5x
PEG
28.21
Very expensive
Sector 0.54|S&P 0.86
Fair value (reverse DCF)
116.00 USD
Fairly priced
P/E vs its own 5-year history
among the 5% highest valuations
At its historical high
Market cap
57.8Md USD
Cash covers 70.1% of the debt, gearing 8.6%.
Net debt / EBITDA
—
Gearing (net debt / equity)
8.61%
Very solid
Cash
6.1Md USD
Cash / market cap
10.59%
Solid
Cash / total debt
70.11%
Very solid
Interest coverage
18.2x
Very solid
Net debt
2.6Md USD
Equity
30.3Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 114.01 USD
- MM20116.04
- MM50120.15
- MM200114.93
- RSI 1437.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.42%
200-day average slope, 3 months
+2.93%
50-day average slope, 1 month
-1.15%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
0.80 % per day
Volatility change
-26.57%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 7.09 (6) | 7.02 (16) | 16 900 (5) | — | 3 575 (6) |
| 2027 | 7.52 (6) | 7.54 (15) | 17 133 (5) | — | 3 613 (6) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of August 26, 2026.
Same sub-industry: 78 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 601318 | 7.7 | N/A | 136Md USD | — | — | 6.5 % | — | — | — | -3.7 % | ||
| 2 | 2628 | 7.6 | 8.7 | 148Md USD | 3.0x | 41.3 % | 36.2 % | 39.0 % | — | 65.0 % | -1.3 % | ||
| 3 | MFC | 6.8 | 6.6 | 72.3Md USD | 16.6x | 10.0 % | 28.2 % | 10.2 % | — | 29.9 % | 42.9 % | ||
| 4 | LICI | 6.7 | N/A | 53.7Md USD | 8.5x | 6.0 % | 7.2 % | — | — | — | -8.8 % | ||
| 5 | MET | 6.6 | 6.0 | 61.8Md USD | 18.6x | 4.6 % | 11.4 % | 7.5 % | — | 26.8 % | 21.0 % | ||
| 6 | GWO | 5.6 | 4.8 | 58.8Md USD | 19.1x | 9.5 % | 21.4 % | 11.7 % | — | 5.0 % | 68.8 % | ||
| 7 | 2881 | 5.4 | 4.6 | 67.3Md USD | 12.9x | 18.1 % | -2.8 % | 10.8 % | — | -9.8 % | 73.3 % | ||
| 8 | AFL | 5.2 | 5.1 | 57.8Md USD | 12.2x | 26.9 % | -1.0 % | 13.1 % | — | 4.6 % | 7.3 % | ||
| 9 | 1299 | 4.7 | 4.7 | 99.4Md USD | 12.7x | 23.2 % | 10.0 % | 14.6 % | — | 1.4 % | 4.0 % |
